Table 5.
Causes of hepatic retransplantation among adult and pediatric recipients under FK506-and CyA-based immunosuppression.
| Cause | Adult | Pediatric | ||
|---|---|---|---|---|
| FK506 (n=1,188) | CyA (n=971) | FK506 (n=203) | CyA (n=241) | |
| Technical failure | 42 (3.5%) | 52 (5.4%)a | 6 (3.0%) | 35 (14.5%)a |
| Graft Failure | 77 (6.5%) | 80 (8.2%) | 13 (6.4%) | 12 (5.0%) |
| Rejection | 18 (1.5%) | 40 (4.1 %)a | 0 (0.0%) | 16 (6.6%)a |
| Graft infection | 4 (0.3%) | 4 (0.4%) | 3 (1.5%) | 7 (2.9%) |
| Disease recurrence | 8 (0.7%) | 24 (2.5%)a | 0 (0.0%) | 1 (0.4%) |
| Others | 4 (0.3%) | 3 (0.3%) | 0 (0.0%) | 1 (0.4%) |
| Total | 153 (12.9%) | 203 (20.9%)a | 22 (10.8%) | 72 (29.9%)a |
CyA=Cyciosporine
a
p<0.05